Molecular subtypes of high-grade serous ovarian cancer: the holy grail?

J Natl Cancer Inst. 2014 Sep 30;106(10):dju297. doi: 10.1093/jnci/dju297. Print 2014 Oct.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Cystadenocarcinoma, Serous / mortality*
  • Cystadenocarcinoma, Serous / therapy*
  • Female
  • Humans
  • Ovarian Neoplasms / mortality*
  • Ovarian Neoplasms / therapy*
  • Transcriptome*

Substances

  • Biomarkers, Tumor